Table 2 Patient characteristics based on whether the patients suspected themselves of having COVID-19 infection or not^a

Age (years), n (%)

 < 0.001

0–15

165

(26.7)

453

(73.3)

16–64

495

(51.0)

475

(49.0)

65–74

35

(40.7)

51

(59.3)

 > 74

40

(31.3)

88

(68.8)

Telephone triage color, n (%)

Yellow

254

(35.2)

468

(64.8)

Orange

425

(45.7)

505

(54.3)

Red

56

(37.3)

94

(62.7)

Diagnosis category, n (%)

Infectious and parasitic diseases

100

(28.9)

246

(71.1)

Endocrine, nutritional, and metabolic diseases

4

(26.7)

11

(73.3)

Mental and behavioral disorders

4

(50.0)

4

(50.0)

Diseases of the nervous system

4

(12.9)

27

(87.1)

Diseases of the ear and mastoid process

4

(12.9)

27

(87.1)

Diseases of the circulatory system

1

(5.9)

16

(94.1)

Diseases of the respiratory system

565

(57.4)

420

(42.6)

Diseases of the digestive system

11

(14.3)

66

(85.7)

Diseases of the skin and subcutaneous tissue

4

(10.3)

35

(89.7)

Diseases of the musculoskeletal system and connective tissue

4

(7.8)

47

(92.2)

Diseases of the genitourinary system

13

(20.3)

51

(79.7)

Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified

8

(12.9)

54

(87.1)

Injury, poisoning, and other certain consequences of external causes

10

(14.5)

59

(85.5)

Other

3

(42.9)

4

(57.1)

Symptom severity, n (%)

Mild

443

(45.2)

537

(54.8)

Moderate

285

(36.4)

499

(63.6)

Severe

7

(18.4)

31

(81.6)

Personal protective equipment used, n (%)

557

(57.7)

408

(42.3)

Diagnostic tools for COVID-19 used, n (%)

377

(83.6)

74

(16.4)

Time of medical examination (minutes), mean (SD)

31.8

(14.7)

28.5

(13.6)

Time of medical examination (minutes), n (%)

 < 15

83

(30.1)

193

(69.9)

16–25

233

(37.3)

392

(62.7)

 ≥ 26

419

(46.5)

482

(53.5)